Chemycal has been acquired by 3E
Learn MoreDiscover how Chemycal PRO helps you boosting your regulatory monitoring:
May 11 (UPI) -- Attorneys general in 43 states and Puerto Rico have filed a joint lawsuit accusing drugmakers of fixing prices for generic drugs used to treat arthritis, diabetes and other serious ailments.
The suit, filed a Connecticut federal court Friday, alleges that pharmaceutical companies conspired to inflate and artificially control prices for more than 100 generic drugs. The suit also names 15 current and former executives in charge of marketing, pricing and sales at drug companies that include Teva Pharmaceutical, Mylan NV and a unit of Pfizer Inc.
CONTINUE READING ON www.upi.com
2013 © MyChemicalMonitoring. ALL Rights Reserved. About Us | Terms and Conditions